Jubilant Pharmova
BSE: 530019 | NSE: JUBLPHARMA | ISIN: INE700A01033 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
8.36Net Income/employee - trailing 12 month
-4,68,578.30Revenue/employee - most recent fiscal year
11,69,78,200.00Return on investment - most recent fiscal year
-0.73Return on average assets - most recent fiscal year
-0.61Receivables turnover - most recent fiscal year
6.65Return on investment - trailing 12 month
-0.51Return on average assets - trailing 12 month
-0.44Inventory turnover - most recent fiscal year
1.64Inventory turnover - trailing 12 month
1.52Revenue/employee - trailing 12 month
6,28,40,500.00Return on average assets - 5 year average
3.95Net Income/employee - most recent fiscal year
-12,08,212.00Return on average equity - trailing 12 month
-0.82Receivables turnover - trailing 12 month
7.03Asset turnover - most recent fiscal year
0.59Asset turnover - trailing 12 month
0.59Return on average equity - most recent fiscal year
-1.14Return on investment - 5 year average
4.78